Advos

Kaufman & Company has broken ground on two geodesic dome data centers in Utah and Texas, featuring a design that cuts water use by 90% and relies heavily on behind-the-meter power, addressing key concerns about AI infrastructure.

Biotech Labz Supply Inc. has broadened its online catalog of high-purity research peptides, now offering 11 compounds with batch-specific certificate of analysis (COA) documentation to support controlled laboratory investigations.

B2i Digital hosts a two-day virtual investor conference featuring OTCQB-listed companies across gold, critical minerals, hydrogen, AI, and biotech, providing direct access to management teams.

Safe Pro Group's latest U.S. government subcontract for its AI threat mapping technology signals growing adoption of AI in defense and a potential revenue boost for the company.

MindWave Innovations' NILA token becomes available on a licensed U.S. exchange, marking a step toward its planned insured Layer 2 blockchain, MindChain, launching in October 2026.

CATL's global market share in EV batteries has risen to 40.2%, reinforcing its leadership and potentially impacting future partnerships with automakers like Massimo Group.

Thermal coal imports into Asia have rebounded for the third month in a row, driven by summer demand from key economies, despite the region's push for renewables, highlighting the ongoing reliance on coal.

Gold's 27% drop from its January peak may disappoint, but it offers a potential buying opportunity, with implications for miners like Platinum Group Metals Ltd.

Oncotelic Therapeutics will showcase its latest clinical progress, including Phase 1b trial advancement and AI-driven platforms, at the OTCQB Virtual Investor Conference, signaling continued momentum in oncology innovation.

Solowin Holdings' AXBHD stablecoin has become the first central bank-regulated stablecoin to receive Sharia certification, marking a significant step for Islamic finance in the digital asset space.

Tonix Pharmaceuticals announced FDA feedback supporting its adaptive Phase 2 study of TNX-4800, a long-acting antibody for Lyme disease prevention, potentially offering a new seasonal preventative option.

NextPlat Corp announced it will report its second quarter 2026 financial results on August 13, 2026, with a conference call to discuss results and business developments.

American Fusion Inc. has completed the first phase of its fusion engine testing, achieving key milestones and validating safety systems, marking a step toward commercial fusion energy.

American Fusion Inc. has appointed Dr. Noah D’Amico as a strategic advisor to enhance its scientific and engineering capabilities as it advances the Texatron Fusion Engine testing program at Texas Tech University.

Gaxos.ai's board approved a $1 million stock buyback, signaling confidence in the company's AI businesses and potentially supporting its share price.

MAX Power Mining's sale of its Willcox Playa Lithium Project to Homeland Critical Minerals, in exchange for a near-50% equity stake, allows it to focus on its Natural Hydrogen strategy while maintaining exposure to lithium.

Helus Pharma has named Michael Halstead as its new CEO, bringing extensive biopharmaceutical experience as the company advances its lead depression candidate through Phase 3 trials and prepares for potential commercialization.

Safe Pro Group projects a massive year-over-year revenue increase for Q2 2026, driven by U.S. Army subcontracts for its AI threat detection software and expansion into ground-based systems.

Recent independent findings suggest that licensed Ebola vaccines may induce cross-reactive immune responses, supporting broader filovirus vaccine development, and GeoVax underscores the strategic value of its MVA-based platform.

Cal-Tech Painting Inc. expands its service to Folsom, offering over three decades of licensed, owner-supervised residential painting with a satisfaction guarantee, emphasizing preparation and color accuracy.

LataMed AI Corp. has entered an agreement with DROGUERIAS LALA C.A. to develop AI and automation tools for pharmaceutical and laboratory operations, potentially expanding its technology into enterprise applications.